Angela partners with Grzegorz Nowakowski, M.D., to lead cancer clinical research, including the Cancer Clinical Trials Office (CCTO), data safety and monitoring, and protocol review and monitoring. Angela and Dr. Nowakowski collaborate with MCCCC practice, disease groups, community outreach and engagement and translational research to execute the transformation of these services to meet patient, stakeholder and NCI expectations.